AB
CRDF icon

Amalgamated Bank’s Cardiff Oncology CRDF Stock Holding History

Amalgamated Bank’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,948
Closed -$5K – 1902
2025
Q4 		$5K Sell
1,948
-61
-3% -$142 ﹤0.01% 2701
2025
Q3 		$4K Hold
2,009
– – ﹤0.01% 2821
2025
Q2 		$6K Hold
2,009
– – ﹤0.01% 2638
2025
Q1 		$6K Buy
2,009
+654
+48% +$2.59K ﹤0.01% 2571
2024
Q4 		$6K Hold
1,355
– – ﹤0.01% 2651
2024
Q3 		$4K Hold
1,355
– – ﹤0.01% 2805
2024
Q2 		$3K Buy
+1,355
New +$5.11K ﹤0.01% 2909
2022
Q2 		– Sell
-4,585
Closed -$11K – 3063
2022
Q1 		$11K Buy
+4,585
New +$16.2K ﹤0.01% 2937

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Amalgamated Bank's CRDF Position: Q1 2026 in Review

Amalgamated Bank sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 1,948 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in CRDF in Q1 2022 and held it in 8 quarters. The position peaked at $11K in Q1 2022. 117 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Amalgamated Bank reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,948 Cardiff Oncology shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Cardiff Oncology in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Cardiff Oncology position peaked at $11K in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.